Kevin Wilson
Company: Foghorn Therapeutics
Job title: Vice President & Head of Chemistry
Seminars:
ROUNDTABLE DISCUSSION: Utilizing Pre-Clinical Data to Predict the Right Dosing Regimen for Your TPD Drug 1:30 pm
day: Day 2, Track 2, PM
Expanding the Therapeutic Frontier: Targeted Protein Degradation in the Chromatin Regulatory System 11:00 am
day: Day 1, Track A, - AM